280 related articles for article (PubMed ID: 9767438)
1. A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus.
Shimizu C; Li X; Kimura M; Hashimoto K; Sugaya K; Kubo M; Suzuki S; Nakayama T
Immunology; 1998 Aug; 94(4):503-12. PubMed ID: 9767438
[TBL] [Abstract][Full Text] [Related]
2. Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720.
Enosawa S; Suzuki S; Kakefuda T; Li XK; Amemiya H
Immunopharmacology; 1996 Sep; 34(2-3):171-9. PubMed ID: 8886861
[TBL] [Abstract][Full Text] [Related]
3. Evidence that FTY720 induces rat thymocyte apoptosis.
Isoyama N; Takai K; Tsuchida M; Matsumura M; Naito K
Transpl Immunol; 2006 Apr; 15(4):265-71. PubMed ID: 16635748
[TBL] [Abstract][Full Text] [Related]
4. The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720.
Suzuki S; Li XK; Shinomiya T; Enosawa S; Amemiya H; Amari M; Naoe S
Clin Exp Immunol; 1997 Jan; 107(1):103-11. PubMed ID: 9010264
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressant FTY720 inhibits thymocyte emigration.
Yagi H; Kamba R; Chiba K; Soga H; Yaguchi K; Nakamura M; Itoh T
Eur J Immunol; 2000 May; 30(5):1435-44. PubMed ID: 10820391
[TBL] [Abstract][Full Text] [Related]
6. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection.
Habicht A; Clarkson MR; Yang J; Henderson J; Brinkmann V; Fernandes S; Jurewicz M; Yuan X; Sayegh MH
J Immunol; 2006 Jan; 176(1):36-42. PubMed ID: 16365393
[TBL] [Abstract][Full Text] [Related]
8. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
9. Evidence that FTY720 induces T cell apoptosis in vivo.
Nagahara Y; Enosawa S; Ikekita M; Suzuki S; Shinomiya T
Immunopharmacology; 2000 Jun; 48(1):75-85. PubMed ID: 10822091
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice.
Luo ZJ; Tanaka T; Kimura F; Miyasaka M
Immunopharmacology; 1999 Apr; 41(3):199-207. PubMed ID: 10428648
[TBL] [Abstract][Full Text] [Related]
11. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion.
Gonzalo JA; Baixeras E; González-García A; George-Chandy A; Van Rooijen N; Martínez C; Kroemer G
J Immunol; 1994 Feb; 152(4):1597-608. PubMed ID: 8120373
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment.
Izeradjene K; Revillard JP
Transplantation; 2001 Jan; 71(1):118-25. PubMed ID: 11211176
[TBL] [Abstract][Full Text] [Related]
13. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of mouse Fas antigen on immature and mature T cells.
Nishimura Y; Ishii A; Kobayashi Y; Yamasaki Y; Yonehara S
J Immunol; 1995 May; 154(9):4395-403. PubMed ID: 7536770
[TBL] [Abstract][Full Text] [Related]
15. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.
Quesniaux V; Fullard L; Arendse H; Davison G; Markgraaff N; Auer R; Ehrhart F; Kraus G; Schuurman HJ
Transpl Immunol; 1999 Sep; 7(3):149-57. PubMed ID: 10608298
[TBL] [Abstract][Full Text] [Related]
16. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes.
Hara H; Takeda A; Takeuchi M; Wakeham AC; Itié A; Sasaki M; Mak TW; Yoshimura A; Nomoto K; Yoshida H
J Immunol; 2002 Mar; 168(5):2288-95. PubMed ID: 11859117
[TBL] [Abstract][Full Text] [Related]
17. T cell selective apoptosis by a novel immunosuppressant, FTY720, is closely regulated with Bcl-2.
Nagahara Y; Ikekita M; Shinomiya T
Br J Pharmacol; 2002 Dec; 137(7):953-62. PubMed ID: 12429567
[TBL] [Abstract][Full Text] [Related]
18. FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL.
Migita K; Origuchi T; Kawabe Y; Tominaga M; Ida H; Kawakami A; Eguchi K
Transplantation; 1999 Oct; 68(7):1018-23. PubMed ID: 10532544
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
[TBL] [Abstract][Full Text] [Related]
20. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing.
Yanagawa Y; Masubuchi Y; Chiba K
Immunology; 1998 Dec; 95(4):591-4. PubMed ID: 9893050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
